Atlas Trials

Bioequivalence Study of Rivastigmine Capsules 1.5 mg of Dr.Reddy's Under Fed Conditions

Clinical trial NCT01146041 · COMPLETED

Trial details

NCT number
NCT01146041
Sponsor
Dr. Reddy's Laboratories Limited
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2004-02-01
Primary completion
2004-02-01
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.